Related Experiment Video
Updated: Dec 12, 2025

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
CD146, from a melanoma cell adhesion molecule to a signaling receptor
Zhaoqing Wang1, Qingji Xu2,3, Nengwei Zhang4
1Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, 100101, Beijing, China. clairezqwang@hotmail.com.
Abstract:
CD146 was originally identified as a melanoma cell adhesion molecule (MCAM) and highly expressed in many tumors and endothelial cells. However, the evidence that CD146 acts as an adhesion molecule to mediate a homophilic adhesion through the direct interactions between CD146 and itself is still lacking. Recent evidence revealed that CD146 is not merely an adhesion molecule, but also a cellular surface receptor of miscellaneous ligands, including some growth factors and extracellular matrixes. Through the bidirectional interactions with its ligands, CD146 is actively involved in numerous physiological and pathological processes of cells. Overexpression of CD146 can be observed in most of malignancies and is implicated in nearly every step of the development and progression of cancers, especially vascular and lymphatic metastasis. Thus, immunotherapy against CD146 would provide a promising strategy to inhibit metastasis, which accounts for the majority of cancer-associated deaths. Therefore, to deepen the understanding of CD146, we review the reports describing the newly identified ligands of CD146 and discuss the implications of these findings in establishing novel strategies for cancer therapy.
Insights
CD146, initially known as melanoma cell adhesion molecule (MCAM), functions as a receptor for various ligands. Its overexpression in cancers highlights its role in metastasis, suggesting CD146-targeted immunotherapy as a promising cancer treatment.
Area of Science:
- Molecular biology
- Cancer research
- Immunology
Background:
- CD146, also known as melanoma cell adhesion molecule (MCAM), is highly expressed in tumors and endothelial cells.
- While initially identified as an adhesion molecule, recent evidence suggests CD146 functions as a receptor for diverse ligands, including growth factors and extracellular matrix components.
- CD146's involvement in cellular processes and its overexpression in malignancies, particularly in cancer metastasis, are increasingly recognized.
Purpose of the Study:
- To review newly identified ligands of CD146.
- To discuss the implications of these ligands in cancer progression and metastasis.
- To explore the potential of CD146-targeted immunotherapy for cancer treatment.
Main Methods:
- Literature review of studies on CD146 ligands.
- Analysis of CD146's role in physiological and pathological cellular processes.
- Evaluation of CD146's involvement in cancer development and metastasis.
Main Results:
- CD146 interacts bidirectionally with various ligands, influencing cellular functions.
- Overexpression of CD146 is linked to cancer progression and metastasis, especially vascular and lymphatic spread.
- Identifying CD146 ligands provides insights into its multifaceted roles in cancer.
Conclusions:
- CD146 is more than an adhesion molecule; it's a crucial receptor involved in cancer progression.
- Targeting CD146 through immunotherapy presents a potential strategy to combat cancer metastasis.
- Further understanding of CD146-ligand interactions can lead to novel therapeutic approaches for cancer.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Selectins
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...

